NEW YORK (GenomeWeb News) – Response Genetics today said that it has extended an agreement with Taiho Pharmaceutical to provide testing and analysis services.

The Los Angeles-based molecular diagnostic firm will provide its services for molecular markers used in research diagnostics and the therapeutic treatment of cancer, it said, adding it will receive at least $950,000 for services provided during the extended period of Jan. 1 to Dec. 31, 2013.

Response and Tokyo-based Taiho first collaborated in 2001.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.